Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-09-17

Clinical Trial Update: Chronic Urticaria - Long Term Assessment of Effects of Rupatadine [Phase 3]

View source ↗

Summary

Phase 3 long-term assessment of rupatadine in chronic urticaria; study terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rupatadine (rupatadine)

Snippet

Sponsor: Charite University, Berlin, Germany | Conditions: Chronic Urticaria | Phase 3 | Status: TERMINATED